These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16509813)

  • 1. Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment.
    Gazzaruso C
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):173-80. PubMed ID: 16509813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erectile dysfunction therapy in special populations and applications: coronary artery disease.
    DeBusk RF
    Am J Cardiol; 2005 Dec; 96(12B):62M-66M. PubMed ID: 16387570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction in patients with coronary artery disease.
    Kloner R; Padma-Nathan H
    Int J Impot Res; 2005; 17(3):209-15. PubMed ID: 15729374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
    Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
    J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erectile dysfunction and phosphodiesterase type 5 inhibitors].
    Roumeguère T; Sternon J; Schulman CC
    Rev Med Brux; 2003 Jun; 24(3):169-75. PubMed ID: 12891884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].
    Ametov AS; Teodorovich OV; Kondrat'eva LV; Popova AIu
    Ter Arkh; 2006; 78(2):92-4. PubMed ID: 16613108
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergency department considerations regarding erectile dysfunction.
    Hollander JE
    Am J Cardiol; 2005 Dec; 96(12B):73M-75M. PubMed ID: 16387572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentaries on Jackson et al. "Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction".
    Kloner RA; Montorsi P; DeBusk RF
    J Sex Med; 2005 Sep; 2(5):740-2; author reply 742. PubMed ID: 16422835
    [No Abstract]   [Full Text] [Related]  

  • 9. Vardenafil (levitra) for erectile dysfunction.
    Med Lett Drugs Ther; 2003 Sep; 45(1166):77-8. PubMed ID: 14506469
    [No Abstract]   [Full Text] [Related]  

  • 10. Chapter 1: The management of erectile dysfunction: an AUA update.
    Montague DK; Jarow JP; Broderick GA; Dmochowski RR; Heaton JP; Lue TF; Milbank AJ; Nehra A; Sharlip ID;
    J Urol; 2005 Jul; 174(1):230-9. PubMed ID: 15947645
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms.
    Kapur V; Schwarz ER
    Rev Cardiovasc Med; 2007; 8(4):214-9. PubMed ID: 18192944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors.
    Lobo JR; Nehra A
    Urol Clin North Am; 2005 Nov; 32(4):447-55, vi. PubMed ID: 16291036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors.
    Jackson G
    Am J Cardiol; 2005 Dec; 96(12B):32M-36M. PubMed ID: 16387564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of erectile dysfunction and risk factors for coronary artery disease.
    Kloner RA
    Int J Impot Res; 2005 Dec; 17 Suppl 1():S7-S11. PubMed ID: 16391547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile dysfunction in the cardiac patient.
    Kloner RA
    Curr Urol Rep; 2003 Dec; 4(6):466-71. PubMed ID: 14622500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of erectile dysfunction in the cardiac patient].
    Gratzke C; Becker AJ; Park JW; Reich O; Waldkirch E; Schlenker B; Stief CG
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2899-903. PubMed ID: 16342015
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
    Francis SH; Corbin JD
    Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phosphodiesterase-5 inhibitor with broad temporal effectiveness window].
    MMW Fortschr Med; 2004 Apr; 146(16):62. PubMed ID: 15222506
    [No Abstract]   [Full Text] [Related]  

  • 19. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
    Lee AG; Newman NJ
    Am J Ophthalmol; 2005 Oct; 140(4):707-8. PubMed ID: 16226524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current opinions on the relationships between atherosclerosis, type 2 diabetes mellitus and erectile dysfunction].
    Gazzaruso C
    Recenti Prog Med; 2005 Mar; 96(3):155-8. PubMed ID: 15929617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.